
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Hamon Center for Therapeutic Oncology Research and Department of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas 75390-9593 [A. K. V., A. F. G.], and Norris Cancer Center and Departments of Surgery and Biochemistry & Molecular Biology [J. A. T., L. Y. C. S., T. I. L., P. W. L., I. A. L-O.], Preventive Medicine [K. D. S.], and Medicine [L. Y. C. S.], Keck School of Medicine, University of Southern California, Los Angeles, California 90089-9176
Recent analyses of global and gene-specific methylation patterns in cancer cells have suggested that cancers from different organs demonstrate distinct patterns of CpG island hypermethylation. Although certain CpG islands are frequently methylated in many different kinds of cancer, others are methylated only in specific tumor types. Because distinct patterns of CpG island hypermethylation can be seen in tumors from different organs, it seems likely that histological subtypes of cancer within a given organ may exhibit distinct methylation patterns as well. The goal of our study was to determine whether the patterns of CpG island hypermethylation could be used to distinguish between different histological subtypes of lung cancer. We analyzed the methylation status of 23 loci in 91 lung cancer cell lines using the quantitative real-time PCR method MethyLight. Genes PTGS2 (COX2), CALCA, MTHFR, ESR1, MGMT, MYOD1, and APC showed statistically significant differences in the level of CpG island methylation between small cell lung cancer (SCLC) and non-small cell lung cancer cell lines (NSCLC). Hierarchical clustering using a panel consisting of these seven loci yielded two major groups, one of which contained 78% of the SCLC lines. Within this group, a large cluster consisted almost exclusively of SCLC cell lines. Our results show that DNA methylation patterns differ between NSCLC and SCLC cell lines and suggest that these patterns could be developed into a powerful molecular marker to achieve accurate diagnosis of lung cancer.
This article has been cited by other articles:
![]() |
M. Brait, S. Begum, A. L. Carvalho, S. Dasgupta, A. L. Vettore, B. Czerniak, O. L. Caballero, W. H. Westra, D. Sidransky, and M. O. Hoque Aberrant Promoter Methylation of Multiple Genes during Pathogenesis of Bladder Cancer Cancer Epidemiol. Biomarkers Prev., October 1, 2008; 17(10): 2786 - 2794. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. K. Wojdacz and A. Dobrovic Methylation-sensitive high resolution melting (MS-HRM): a new approach for sensitive and high-throughput assessment of methylation Nucleic Acids Res., March 19, 2007; 35(6): e41 - e41. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Wang, H. Liu, Z. Zhang, M. R. Spitz, and Q. Wei Association of Genetic Variants of O6-Methylguanine-DNA Methyltransferase with Risk of Lung Cancer in Non-Hispanic Whites Cancer Epidemiol. Biomarkers Prev., December 1, 2006; 15(12): 2364 - 2369. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. O. Hoque, Q. Feng, P. Toure, A. Dem, C. W. Critchlow, S. E. Hawes, T. Wood, C. Jeronimo, E. Rosenbaum, J. Stern, et al. Detection of Aberrant Methylation of Four Genes in Plasma DNA for the Detection of Breast Cancer J. Clin. Oncol., September 10, 2006; 24(26): 4262 - 4269. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. R. Vuillemenot, J. A. Hutt, and S. A. Belinsky Gene Promoter Hypermethylation in Mouse Lung Tumors Mol. Cancer Res., April 1, 2006; 4(4): 267 - 273. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. D. Siegmund, A. J. Levine, J. Chang, and P. W. Laird Modeling exposures for DNA methylation profiles. Cancer Epidemiol. Biomarkers Prev., March 1, 2006; 15(3): 567 - 572. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. O. Hoque, O. Topaloglu, S. Begum, R. Henrique, E. Rosenbaum, W. Van Criekinge, W. H. Westra, and D. Sidransky Quantitative Methylation-Specific Polymerase Chain Reaction Gene Patterns in Urine Sediment Distinguish Prostate Cancer Patients From Control Subjects J. Clin. Oncol., September 20, 2005; 23(27): 6569 - 6575. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Lehmann, I. Berg-Ribbe, L. U. Wingen, K. Brakensiek, T. Becker, J. Klempnauer, B. Schlegelberger, H. Kreipe, and P. Flemming Distinct Methylation Patterns of Benign and Malignant Liver Tumors Revealed by Quantitative Methylation Profiling Clin. Cancer Res., May 15, 2005; 11(10): 3654 - 3660. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Jeronimo, R. Henrique, M. O. Hoque, E. Mambo, F. R. Ribeiro, G. Varzim, J. Oliveira, M. R. Teixeira, C. Lopes, and D. Sidransky A Quantitative Promoter Methylation Profile of Prostate Cancer Clin. Cancer Res., December 15, 2004; 10(24): 8472 - 8478. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. Muller, S. Millinger, H. Fiegl, G. Goebel, L. Ivarsson, A. Widschwendter, E. Muller-Holzner, C. Marth, and M. Widschwendter Analysis of Methylated Genes in Peritoneal Fluids of Ovarian Cancer Patients: A New Prognostic Tool Clin. Chem., November 1, 2004; 50(11): 2171 - 2173. [Full Text] [PDF] |
||||
![]() |
M. L. Gonzalgo, S. Yegnasubramanian, G. Yan, C. G. Rogers, T. L. Nicol, W. G. Nelson, and C. P. Pavlovich Molecular Profiling and Classification of Sporadic Renal Cell Carcinoma by Quantitative Methylation Analysis Clin. Cancer Res., November 1, 2004; 10(21): 7276 - 7283. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. F. Gazdar, K. Miyajima, J. Reddy, U. G. Sathyanarayana, H. Shigematsu, M. Suzuki, T. Takahashi, and N. Shivapurkar Molecular Targets for Cancer Therapy and Prevention Chest, May 1, 2004; 125(5_suppl): 97S - 101S. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-I. Kim Folate and DNA Methylation: A Mechanistic Link between Folate Deficiency and Colorectal Cancer? Cancer Epidemiol. Biomarkers Prev., April 1, 2004; 13(4): 511 - 519. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Marchevsky, J. A. Tsou, and I. A. Laird-Offringa Classification of Individual Lung Cancer Cell Lines Based on DNA Methylation Markers: Use of Linear Discriminant Analysis and Artificial Neural Networks J. Mol. Diagn., February 1, 2004; 6(1): 28 - 36. [Abstract] [Full Text] |
||||
![]() |
M. F. Paz, M. F. Fraga, S. Avila, M. Guo, M. Pollan, J. G. Herman, and M. Esteller A Systematic Profile of DNA Methylation in Human Cancer Cell Lines Cancer Res., March 1, 2003; 63(5): 1114 - 1121. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-J. Sohn, J. M. Stempak, S. Reid, S. Shirwadkar, J. B. Mason, and Y.-I. Kim The effect of dietary folate on genomic and p53-specific DNA methylation in rat colon Carcinogenesis, January 1, 2003; 24(1): 81 - 90. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |